RESUMO
OBJECTIVE: Mycoplasma genitalium (MG) is a microorganism related to sexually transmitted infections. Antibiotic resistance of MG leads to an increase in treatment failure rates and the persistence of the infection. The aim of this study was to describe the most frequent mutations associated with azithromycin and moxifloxacin resistance in our geographical area. METHODS: A prospective study from May 2019 to May 2023 was performed. MG-positive samples were collected. Real-time PCRs (AllplexTM MG-AziR Assay and AllplexTM MG-MoxiR Assay, Seegene) were performed in MG positive samples to detect mutations in 23S rRNA V domain and parC gene. RESULTS: A 37.1% of samples presented resistance determinants to azithromycin and the most common mutation detected was A2059G (57.9%). Resistance to moxifloxacin was studied in 72 azithromycin-resistant samples and 36.1% showed mutations, being G248T the most prevalent (73.1%). CONCLUSIONS: The resistance to different lines of treat ment suggests the need for a targeted therapy and the performing of a test of cure afterwards.
Assuntos
Antibacterianos , Azitromicina , Farmacorresistência Bacteriana , Moxifloxacina , Mutação , Infecções por Mycoplasma , Mycoplasma genitalium , Mycoplasma genitalium/efeitos dos fármacos , Mycoplasma genitalium/genética , Moxifloxacina/farmacologia , Moxifloxacina/uso terapêutico , Azitromicina/farmacologia , Azitromicina/uso terapêutico , Espanha , Humanos , Estudos Prospectivos , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Farmacorresistência Bacteriana/genética , Infecções por Mycoplasma/tratamento farmacológico , Infecções por Mycoplasma/microbiologia , Feminino , Masculino , Testes de Sensibilidade Microbiana , RNA Ribossômico 23S/genética , Adulto , DNA Topoisomerase IV/genéticaAssuntos
Humanos , Masculino , Idoso , Policondrite Recidivante , Hematologia , Síndromes Mielodisplásicas , Inflamação , Ferimentos e Lesões , Fibrilação Atrial , Epididimite , PancitopeniaAssuntos
Humanos , Masculino , Idoso , Policondrite Recidivante , Hematologia , Síndromes Mielodisplásicas , Inflamação , Ferimentos e Lesões , Fibrilação Atrial , Epididimite , PancitopeniaRESUMO
OBJECTIVE: To determine whether sacral transcutaneous electrical nerve stimulation (S-TENS) is an effective treatment in patients refractory to anticholinergic drugs (Achs). MATERIALS AND METHODS: A prospective multi-center study of patients with overactive bladder (OB) refractory to Achs treated with S-TENS from 2018 to 2021 was carried out. S-TENS was applied over 3 months. Symptom progression was assessed using the voiding calendar and the Pediatric Lower Urinary Tract Symptoms Score (PLUTSS), excluding questions 3 and 4 -referring to enuresis- so that progression of daytime symptoms only (LUTS variable) was analyzed. RESULTS: 66 patients -50% of whom were female- were included, with a mean age of 9.5 years (range: 5-15). S-TENS significantly lowered PLUTSS (19.1 baseline vs. 9.5 final, p< 0.001) and LUTS (13.1 baseline vs. 4.8 final, p< 0.001). It also reduced the number of mictions (8.5 baseline vs. 6.4 final, p< 0.001), while increasing urine volume in the voiding records (214 ml baseline vs. 258 ml final, p< 0.001). Enuresis was the only variable refractory to S-TENS. Complication rate was 3% (2 patients with dermatitis in the S-TENS application area). CONCLUSIONS: S-TENS is effective and safe in the short-term in patients with OB refractory to Achs. Further studies assessing long-term efficacy and potential relapses are required.
OBJETIVOS: Determinar si la electroterapia nerviosa transcutánea a nivel sacro (TENS-S) es un tratamiento efectivo en pacientes refractarios a fármacos anticolinérgicos (Ach). MATERIAL Y METODOS: Estudio prospectivo y multicéntrico: pacientes con VH refractaria a Ach tratados con TENS-S entre 2018-2021. El TENS-S se aplicó durante 3 meses. La evolución sintomática fue evaluada utilizando el calendario miccional y el cuestionario PLUTSS (Pediatric Lower Urinary Tract Symptoms Score), pero excluyendo sus preguntas 3 y 4 (referidas a la enuresis) para analizar solamente la evolución de la sintomatología diurna (variable LUTS). RESULTADOS: Fueron incluidos 66 pacientes (50% niñas), con una edad media de 9,5 años (rango: 5-15). El TENS-S disminuyó significativamente el PLUTSS (19,1 inicial vs 9,5 final, p< 0,001) y el LUTS (13,1 inicial vs 4,8 final, p< 0,001). Además, redujo el número de micciones (8,5 inicial vs 6,4 final, p< 0,001) y aumentó el volumen de orina en los registros miccionales (214 ml inicial vs 258 ml final, p< 0,001). La enuresis fue la única variable refractaria al TENS-S. La tasa de complicaciones fue del 3% (2 pacientes, dermatitis en el área de aplicación del TENS-S). CONCLUSIONES: El TENS-S es efectivo y seguro a corto plazo en pacientes con VH refractarios a los Ach. Deben realizarse estudios para evaluar la eficacia a largo plazo y posibles recaídas.
Assuntos
Enurese , Estimulação Elétrica Nervosa Transcutânea , Bexiga Urinária Hiperativa , Incontinência Urinária , Humanos , Criança , Feminino , Masculino , Bexiga Urinária Hiperativa/terapia , Estimulação Elétrica Nervosa Transcutânea/efeitos adversos , Estudos Prospectivos , Antagonistas Colinérgicos/uso terapêutico , Incontinência Urinária/terapia , Resultado do Tratamento , Enurese/tratamento farmacológico , Enurese/etiologiaRESUMO
Objetivos: Determinar si la electroterapia nerviosa transcutánea anivel sacro (TENS-S) es un tratamiento efectivo en pacientes refractariosa fármacos anticolinérgicos (Ach).Material y métodos: Estudio prospectivo y multicéntrico: pacientes con VH refractaria a Ach tratados con TENS-S entre 2018-2021. El TENS-S se aplicó durante 3 meses. La evolución sintomática fueevaluada utilizando el calendario miccional y el cuestionario PLUTSS(Pediatric Lower Urinary Tract Symptoms Score), pero excluyendo suspreguntas 3 y 4 (referidas a la enuresis) para analizar solamente laevolución de la sintomatología diurna (variable LUTS).Resultados: Fueron incluidos 66 pacientes (50% niñas), con unaedad media de 9,5 años (rango: 5-15). El TENS-S disminuyó significativamente el PLUTSS (19,1 inicial vs 9,5 final, p< 0,001) y el LUTS (13,1inicial vs 4,8 final, p< 0,001). Además, redujo el número de micciones(8,5 inicial vs 6,4 final, p< 0,001) y aumentó el volumen de orina enlos registros miccionales (214 ml inicial vs 258 ml final, p< 0,001). Laenuresis fue la única variable refractaria al TENS-S. La tasa de complicaciones fue del 3% (2 pacientes, dermatitis en el área de aplicacióndel TENS-S). Conclusiones: El TENS-S es efectivo y seguro a corto plazo enpacientes con VH refractarios a los Ach. Deben realizarse estudios paraevaluar la eficacia a largo plazo y posibles recaídas.(AU)
Objective: To determine whether sacral transcutaneous electricalnerve stimulation (S-TENS) is an effective treatment in patients refractory to anticholinergic drugs (Achs).Materials and methods. A prospective multi-center study of patients with overactive bladder (OB) refractory to Achs treated with S-TENS from 2018 to 2021 was carried out. S-TENS was applied over 3months. Symptom progression was assessed using the voiding calendarand the Pediatric Lower Urinary Tract Symptoms Score (PLUTSS),excluding questions 3 and 4 referring to enuresis so that progressionof daytime symptoms only (LUTS variable) was analyzed. Results: 66 patients 50% of whom were female were included,with a mean age of 9.5 years (range: 5-15). S-TENS significantly lowered PLUTSS (19.1 baseline vs. 9.5 final, p< 0.001) and LUTS (13.1baseline vs. 4.8 final, p< 0.001). It also reduced the number of mictions(8.5 baseline vs. 6.4 final, p< 0.001), while increasing urine volume inthe voiding records (214 ml baseline vs. 258 ml final, p< 0.001). Enuresiswas the only variable refractory to S-TENS. Complication rate was 3%(2 patients with dermatitis in the S-TENS application area).Conclusions: S-TENS is effective and safe in the short-term inpatients with OB refractory to Achs. Further studies assessing long-termefficacy and potential relapses are required.(AU)
Assuntos
Humanos , Masculino , Feminino , Criança , Bexiga Urinária Hiperativa/tratamento farmacológico , Terapia por Estimulação Elétrica/métodos , Antagonistas Colinérgicos/administração & dosagem , Bexiga Urinária Hiperativa/terapia , Estudos Prospectivos , Pediatria , Sistema Urinário/efeitos dos fármacos , Incidência , Espanha , Inquéritos e Questionários , Interpretação Estatística de DadosRESUMO
Background: Meatal advancement with glanduloplasty (MAGPI) has been in the recent years one of the most frequently surgical techniques used for the correction of distal hypospadias. Multiple modifications have been described to improve the results ofthis technique. In 2004 we presented the initial results of the New Modern MAGPI or DUAGPI (distal urethral advancement and glanduloplasty) as a surgical alternative to the original MAGPI. Objetive: The objective of the present study is to evaluate the applicability, safety and the cosmetic results obtained with this technique, as well as the long-term complications. Materials and Methods: Retrospective and descriptive study of patients with distal hypospadias, corrected using the DUAPI technique, between 2002 and 2018. Surgical technique: Initially, an artificial erection was performed, the absence of curvature in all patients is proven. A skin denudation was performed up to the base of the penis in those children with a bend greater than 30. Second, the distal urethral disconnection was performed at the posterior and lateral urethral level. A glandular triangular section is made to accommodate the distal urethra and to allow a conical appearance with a final glandular. Finally, the fixation of the distal urethral to the glandular tip and the anterior glandular closure is performed. We performed an annual follow-up of all patients. The analysis of all the variables collected during surgery and follow-up was done with SPSS 22 statistical package. Results: 90 patients meet inclusion criteria and were included in the study (32 glandular and 58 coronal). The mean surgical time was 47 minutes (Range: 37-71 minutes). The mean follow-up was 9.4 years (2.1-15 years). 2 patients had meatal stenosis after surgery, 4 mild glandular retraction, and 2 urethrocutaneous fistula. Six of the 8 patients with a complication were successfully reoperated (AU)
Introducción: El avance meatal con glanduloplastia (MAGPI) ha sido una de las técnicas quirúrgicas másutilizadas para la corrección de los hypospadias distales.Desde su descripción inicial, multiples modificaciones hansido descritas para mejorar los resultados de esta técnica.En 2004, nosotros presentamos los resultados iniciales delNew Modern MAGPI o DUAGPI (avance uretral distaly glanduloplastia) como alternativa quirúrgica al MAGPIoriginal, y la hemos utilizado durante los últimos 15 años.Objetivo: El objetivo del presente estudio es evaluar la aplicabilidad, seguridad y los resultados estéticosobtenidos con esta técnica, así como sus complicaciones alargo plazo.Material y Métodos: Estudio retrospectivo y descriptivo, de pacientes con hipospadias con meato a nivel distal, corregidos utilizando la técnica DUAGPI, entre 2002y 2018. Técnica quirúrgica: Inicialmente realizamos unaerección artificial. La ausencia de curvatura en todos lospacientes fue comprobada . Se realiza la denudación peneshasta la base en los penes con una curvatura mayor a 30º. Secundariamente, se realiza la disección de la uretra distal en sus caras laterales y dorsal . Una sección glandular triangular se realiza para acomodar la uretra distal, logrando además un aspecto cónico y natural del glande . Finalmente, se realiza la fijación de la uretra distal avanzaday el cierre glandular . Realizamos un seguimiento anualde los pacientes, evaluando las complicaciones y los resultados estéticos tras la cirugía. El análisis de las variablesrecolectadas fue realizado con el paquete estadístico SPSS22.Resultados: 90 pacientes fueron incluidos en el estudio (32 hipospadias glandulares y 58 coronales), conuna edad media en el momento de la cirugía de 23 meses(Rango: 15-54). La media de tiempo quirúrgico...(AU)
Assuntos
Humanos , Masculino , Adolescente , Adulto Jovem , Adulto , Pessoa de Meia-Idade , Procedimentos Cirúrgicos Urológicos Masculinos/métodos , Hipospadia/cirurgia , Seguimentos , Estudos Retrospectivos , Resultado do TratamentoAssuntos
Infecções por Chlamydia , Complicações Infecciosas na Gravidez , Infecções Sexualmente Transmissíveis , Adulto , Infecções por Chlamydia/epidemiologia , Chlamydia trachomatis , Feminino , Humanos , Gravidez , Complicações Infecciosas na Gravidez/epidemiologia , Gestantes , Prevalência , Infecções Sexualmente Transmissíveis/epidemiologia , Espanha/epidemiologiaRESUMO
Introducción y objetivo: La electroestimulación vesical ha surgido como nueva alternativa en el manejo de pacientes adultos con disfunciones vesicales de origen neuropático. A pesar de que numerosos trabajos han probado la eficacia y la seguridad de esta terapia en este grupo de edad, todavía son escasos los estudios que demuestran su éxito en la vejiga neuropática pediátrica. Material y métodos. Realizamos una revisión sistemática de los estudios que evalúan el impacto de la electroestimulación vesical en pacientes pediátricos (0-18 años) con vejiga de origen neurógeno. La búsqueda identificó 9.716 artículos potencialmente elegibles. Finalmente, 11 trabajos publicados entre 1992 y 2019 cumplieron los criterios necesarios para formar parte del estudio y fueron seleccionados para la presente revisión sistemática. Resultados: No encontramos una tendencia común entre los resultados obtenidos de los estudios incluidos en la presente revisión. A pesar de que la mayoría de ellos demostró individualmente una tasa de eficacia óptima y una alta seguridad, la superioridad de esta terapia frente a los fármacos anticolinérgicos no pudo establecerse. Por tanto, hasta la fecha, sus resultados continúan siendo controvertidos. Además, la metodología entre los diferentes estudios fue muy diversa, lo que dificultó la comparación entre los resultados obtenidos de cada uno de ellos. Conclusiones: Dado el potencial riesgo de insuficiencia renal que presentan los pacientes pediátricos con vejiga neurógena, las alternativas terapéuticas utilizadas en su manejo deben tener una eficacia demostrada. Así, ante la ausencia de evidencia con respecto a la electroestimulación vesical en este grupo de pacientes, por el momento su utilización debería ser limitada y excepcional.
Introduction and objective: Bladder neuromodulation has emerged as a new alternative in the management of adults with bladder dysfunctions from a neuropathic origin. Despite the fact that, numerous studies have proven the efficacy and safety of this therapy in adults patients, there are however, still few studies that demonstrate its success in paediatric neuropathic bladder. Materials and methods: We perform a systematic review of the studies which analysed the impact of bladder electrostimulation in paediatric patients (0 to 18 years) with a neurogenic origin. The search identified 9716 potentially articles. Finally, 11 papers published between 1992 and 2019 fulfilled the necessary criteria to be part of our study and were selected for the systematic review. Results: We did not find a common trend among the results obtained from the studies included in the present review. Most of the studies demonstrated an optimal efficacy rate and high safety, but however the superiority of this therapy over anticholinergic drugs could not be established due the presented results. For this fact, these results continue to be controversial. Furthermore, the methodology between the different studies was very huge, which made it difficult to compare the results obtained from each one of them. Conclusions: Given the potential risk of renal failure presented by paediatric patients with neurogenic bladder, the therapeutic alternatives used in the management of this disease must have a proven efficacy. For this reason, and after the review, due the absence of evidence regarding bladder electrotherapy in this group of patients, its use should be limited and exceptional. Bladder neuromodulation has emerged as a new alternative in the management of adult patients with bladder dysfunctions of neuropathic origin...(AU)
Assuntos
Humanos , Masculino , Feminino , Bexiga Urinaria Neurogênica , Disrafismo Espinal , Incontinência Urinária , Meningomielocele , Neurologia , Doenças do Sistema Nervoso , PediatriaRESUMO
INTRODUCTION AND OBJECTIVE: Bladder neuromodulation has emerged as a new alternative in the management of adults with bladder dysfunctions from a neuropathic origin. Despite the fact that, numerous studies have proven the efficacy and safety of this therapy in adults' patients, there are however, still few studies that demonstrate its success in paediatric neuropathic bladder. MATERIALS AND METHODS: We perform a systematic review of the studies which analysed the impact of bladder electrostimulation in paediatric patients (0 to 18 years) with a neurogenic origin. The search identified 9716 potentially articles. Finally, 11 papers published between 1992 and 2019 fulfilled the necessary criteria to be part of our study and were selected for the systematic review. RESULTS: We did not find a common trend among the results obtained from the studies included in the present review. Most of the studies demonstrated an optimal efficacy rate and high safety, but however the superiority of this therapy over anticholinergic drugs could not be established due the presented results. For this fact, these results continue to be controversial. Furthermore, the methodology between the different studies was very huge, which made it difficult to compare the results obtained from each one of them. CONCLUSIONS: Given the potential risk of renal failure presented by paediatric patients with neurogenic bladder, the therapeutic alternatives used in the management of this disease must have a proven efficacy. For this reason, and after the review, due the absence of evidence regarding bladder electrotherapy in this group of patients, its use should be limited and exceptional. Bladder neuromodulation has emerged as a new alternative in the management of adult patients with bladder dysfunctions of neuropathic origin. Despite the fact that numerous studies have proven the efficacy and safety of this therapy in this age group, there are still few studies that show its success in paediatric neuropathic bladder.
TITLE: Puesta al día en electroestimulación vesical y vejiga neurógena en pediatría: una revisión sistemática.Introducción y objetivo. La electroestimulación vesical ha surgido como nueva alternativa en el manejo de pacientes adultos con disfunciones vesicales de origen neuropático. A pesar de que numerosos trabajos han probado la eficacia y la seguridad de esta terapia en este grupo de edad, todavía son escasos los estudios que demuestran su éxito en la vejiga neuropática pediátrica. Material y métodos. Realizamos una revisión sistemática de los estudios que evalúan el impacto de la electroestimulación vesical en pacientes pediátricos (0-18 años) con vejiga de origen neurógeno. La búsqueda identificó 9.716 artículos potencialmente elegibles. Finalmente, 11 trabajos publicados entre 1992 y 2019 cumplieron los criterios necesarios para formar parte del estudio y fueron seleccionados para la presente revisión sistemática. Resultados. No encontramos una tendencia común entre los resultados obtenidos de los estudios incluidos en la presente revisión. A pesar de que la mayoría de ellos demostró individualmente una tasa de eficacia óptima y una alta seguridad, la superioridad de esta terapia frente a los fármacos anticolinérgicos no pudo establecerse. Por tanto, hasta la fecha, sus resultados continúan siendo controvertidos. Además, la metodología entre los diferentes estudios fue muy diversa, lo que dificultó la comparación entre los resultados obtenidos de cada uno de ellos. Conclusiones. Dado el potencial riesgo de insuficiencia renal que presentan los pacientes pediátricos con vejiga neurógena, las alternativas terapéuticas utilizadas en su manejo deben tener una eficacia demostrada. Así, ante la ausencia de evidencia con respecto a la electroestimulación vesical en este grupo de pacientes, por el momento su utilización debería ser limitada y excepcional.
Assuntos
Terapia por Estimulação Elétrica , Bexiga Urinaria Neurogênica/terapia , Criança , HumanosRESUMO
In feedstocks containing high ammonia (NH3) concentration, removal of the NH3 during the anaerobic digestion (AD) process can improve AD process performance. In the present study, the effect of NH3 removal using gas-permeable membrane (GPM) technology on AD process performance and biogas production was investigated using swine manure feedstock. Batch and semi-continuous AD experiments were carried out under mesophilic conditions. In the reactor with NH3 recovery, total ammonia nitrogen (TAN) concentration was reduced 28% in batch experiments and 23% on average in the semicontinuous experiment compared with the reactor without NH3 recovery. Free ammonia (FA) concentrations were also decreased by 23% and 4% on average in batch and semicontinuous experiments, respectively. These reductions in TAN and FA by GPM system positively impacted both the quality and quantity of the biogas produced by AD of swine manure. Specifically, the specific methane yield increased 9% in the batch experiment and 17% on average in the semicontinuous experiment. Furthermore, higher percentages of methane in biogas were obtained during AD retrofitted with GPM system, 24% increase in the batch experiment and 11% on average in the semicontinuous experiment (range 8.3-13.6%). Simultaneously, a uniform TAN recovery rate of 6.7 g N TAN per m2 of membrane and per day was obtained for the 205 days of semicontinuous operation; ammonia nitrogen was recovered in the form of ammonium sulphate solution. Therefore, the AD-GPM configuration produces beneficial results on biogas quantity and quality while recovering ammonia nitrogen in form of ammonium sulphate.
Assuntos
Amônia , Esterco , Amônia/análise , Anaerobiose , Animais , Biocombustíveis , Reatores Biológicos , Metano , SuínosRESUMO
La incontinencia urinaria es uno de los motivos de visita más frecuentes al urólogo pediátrico, y la vejiga hiperactiva es la disfunción del tracto urinario inferior que más frecuentemente presenta este síntoma. Actualmente, el único fármaco aprobado para el manejo de la vejiga hiperactiva en pediatría es la oxibutinina; sin embargo, muchos pacientes responden parcialmente a esta terapia o son refractarios a la misma. La electroterapia vesical ha surgido como nueva alternativa en el algoritmo de manejo de los pacientes con vejiga hiperactiva refractaria a los fármacos anticolinérgicos, pero la evidencia bibliográfica al respecto hasta la fecha es escasa. Presentamos el caso de una paciente de 12 años con vejiga hiperactiva refractaria a oxibutinina y solifinacina que presentó una buena respuesta al tratamiento con electroterapia vesical sacra, con desaparición completa de los síntomas (incontinencia diurna y urgencia miccional), sin efectos adversos
Urinary incontinence is one of the principal reasons for visiting the urologist amongst paediatric patients, and an overactive bladder is the vesical dysfunction that most frequently provokes this. Currently the only medicine approved for managing an overactive bladder is oxybutynin; however, many patients respond partially to this therapy or are refractory to it. Vesical electrotherapy has emerged as a new alternative in the algorithm for managing patients with an overactive bladder refractory to anticholinergic medicines, but the evidence on this issue has to date been scant. We present the case of a 12-year-old patient with an overactive bladder refractory to oxybutynin and solifenacin who presented a good response to treatment with sacral vesical electrotherapy, with complete disappearance of the symptoms (diurnal incontinence and urgency of micturition) without adverse effects
Assuntos
Humanos , Feminino , Criança , Estimulação Elétrica Nervosa Transcutânea/métodos , Bexiga Urinária Hiperativa/terapia , Resultado do TratamentoRESUMO
INTRODUCTION AND OBJECTIVES: The diagnosis of IgE-mediated cow's milk allergy (CMA) is often based on clinical history and on specific IgE levels and/or skin-prick tests (SPT), both of which are sensitive but not specific. The gold standard, oral food challenge (OFC), is expensive and time-consuming and involves a risk of severe allergic reactions. This study aimed to determine the value of specific IgEs, ratios of specific IgEs for cow's milk and its components to total IgE, and wheal size on SPT for predicting a positive OFC for CMA. MATERIAL AND METHODS: We retrospectively studied 72 patients [median age, four years; age range 0.75-15 years] sensitized to cow's milk who underwent OFCs to milk. predictive variables between patients with positive and negative OFCs were compared. Receiver operator characteristic (ROC) curves were uses to assess variables' discriminatory capacity and Youden's index to determine the best cut-offs for predicting CMA. RESULTS: The OFC was positive in 39 (54%) patients. Wheal size on SPT and all specific IgEs and specific-to-total IgE ratios were significantly different between patients with positive OFCs and those with negative OFCs (p < 0.001). The variable with the greatest area under the ROC curve was casein-specific IgE (0.98), followed by β-lactoglobulin-specific IgE (0.923), casein-specific-to-total-IgE ratio (0.919), and α-lactalbumin-specific IgE (0.908). Casein-specific IgE ≥ 0.95kU/L yielded 88.9% sensitivity and 90.9% specificity. CONCLUSIONS: In our center, casein-specific IgE > 0.95kU/L can obviate an OFC to cow's milk for the diagnosis of CMA in patients sensitized to cow's milk with a compatible history
No disponible
Assuntos
Humanos , Masculino , Feminino , Lactente , Pré-Escolar , Criança , Adolescente , Hipersensibilidade a Leite/diagnóstico , Substitutos do Leite Humano , Imunoglobulina E/sangue , Estudos Retrospectivos , Hipersensibilidade a Leite/imunologia , Padrões de Referência , Caseínas/sangue , Caseínas/imunologia , Lactalbumina/sangue , Lactalbumina/imunologia , Curva ROC , Estatísticas não Paramétricas , Valores de Referência , Valor Preditivo dos Testes , Testes de Irritação da PeleRESUMO
Urinary incontinence is one of the principal reasons for visiting the urologist amongst paediatric patients, and an overactive bladder is the vesical dysfunction that most frequently provokes this. Currently the only medicine approved for managing an overactive bladder is oxybutynin; however, many patients respond partially to this therapy or are refractory to it. Vesical electrotherapy has emerged as a new alternative in the algorithm for managing patients with an overactive bladder refractory to anticholinergic medicines, but the evidence on this issue has to date been scant. We present the case of a 12-year-old patient with an overactive bladder refractory to oxybutynin and solifenacin who presented a good response to treatment with sacral vesical electrotherapy, with complete disappearance of the symptoms (diurnal incontinence and urgency of micturition) without adverse effects.
Assuntos
Terapia por Estimulação Elétrica , Bexiga Urinária Hiperativa , Incontinência Urinária , Criança , Humanos , Succinato de Solifenacina , Resultado do TratamentoRESUMO
p16 hypermethylation in Barrett's carcinogenesis has been evaluated in studies which did not take into account sample heterogeneity and yielded qualitative (methylated/unmethylated) instead of accurate quantitative (percentage of CpG methylation) data. We aimed to measure the degree of p16 methylation in pure samples representing all the steps of Barrett's tumorogenesis and to evaluate the influence of sample heterogeneity in methylation analysis. METHODS: 77 paraffin-embedded human esophageal samples were analyzed. Histological grading was established by two pathologists in: negative for dysplasia, indefinite for dysplasia, low-grade dysplasia, high-grade dysplasia and adenocarcinoma. Areas of interest were selected by laser-capture microdissection. p16 methylation was quantified by pyrosequencing. An adjacent section of the whole sample was also analyzed to compare methylation data. RESULTS: After microdissection, we obtained 15 samples of squamous epithelium, 36 non-dysplastic Barrett's esophagus, 3 indefinite for dysplasia, 24 low-grade dysplasia, 4 high-grade dysplasia and 12 adenocarcinoma. Squamous epithelium showed the lowest methylation rates: 6% (IQR 5-11) vs. 11%(7-39.50) in negative/indefinite for dysplasia, p<0.01; 10.60%(6-24) in low-grade dysplasia, p<0.05; and 44.50%(9-66.75) in high-grade dysplasia/adenocarcinoma, p<0.01. This latter group also exhibited higher methylation rates than Barrett's epithelium with and without low-grade dysplasia (p<0.05). p16 methylation rates of microdissected and non-microdissected samples did not correlate unless the considered histological alteration comprised >71% of the sample. CONCLUSIONS: p16 methylation is an early event in Barrett's carcinogenesis which increases with the severity of histological alteration. p16 methylation rates are profoundly influenced by sample heterogeneity, so selection of samples is crucial in order to detect differences.